Latest profit margin for Basilea Pharmaceutica AG: 27.13% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for BPMUF is 27.13% as of June 2026. That compares with 17.19% in the prior-year period — up 57.8% year over year. That is above the Healthcare sector average of 17.63%. Investors often review this figure alongside Basilea Pharmaceutica AG's historical trend and sector peers before judging valuation or financial health.
Over the past year, BPMUF's profit margin moved from 17.19% to 27.13% — a 57.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Basilea Pharmaceutica AG's valuation or profitability profile.
Against Healthcare companies, BPMUF currently prints 27.13% for profit margin, while the sector average sits near 17.63%. That is roughly 53.9% above the sector mean. Large gaps often invite a closer look at Basilea Pharmaceutica AG's growth, margins, and balance sheet.
Profit Margin shows how effectively Basilea Pharmaceutica AG converts resources into returns. At 27.13%, BPMUF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 17.19% in the prior-year period — up 57.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BPMUF's profit margin (27.13%), review year-over-year change from 17.19%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.